{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:42:09Z","timestamp":1782276129453,"version":"3.54.5"},"reference-count":38,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01AG080516"],"award-info":[{"award-number":["1R01AG080516"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute of Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"The Netherlands Organisation for Health Research and Development","doi-asserted-by":"crossref","award":["171002102"],"award-info":[{"award-number":["171002102"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001826","name":"The Netherlands Organisation for Health Research and Development","doi-asserted-by":"crossref","award":["80-87700-98-22190"],"award-info":[{"award-number":["80-87700-98-22190"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Horizon 2020 Research and Innovation Programme","award":["63398"],"award-info":[{"award-number":["63398"]}]},{"name":"Horizon 2020 Research and Innovation Programme","award":["HORIZON-HLTH-2022-TOOL-11"],"award-info":[{"award-number":["HORIZON-HLTH-2022-TOOL-11"]}]},{"name":"Horizon 2020 Research and Innovation Programme","award":["101095407"],"award-info":[{"award-number":["101095407"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The first primary aldosteronism (PA) case, documented in 1954, was attributed to a sizable aldosterone-producing adenoma, which was palpable during exploratory surgery. By the 1960s, expected aldosterone-producing adenomas in several other, equally severe PA cases escaped localization with ether radiographic modalities available at the time (aortography and retroperitoneal pneumography) or during intraoperative exploration. Adrenal vein sampling (AVS) was, hence, introduced in an effort to accurately guide adrenalectomy. Computed tomography eventually became available in the 1970s, albeit with limited initial performance. Over the following decades, cross-sectional imaging underwent major advancements in spatial resolution, scanning time, and manufacturing capacity, broadening its use at a global scale. Nevertheless, AVS has remained the most trusted modality for identifying PA cases that could benefit from surgery. This clinical practice standard has been anchored in 2 major arguments: (1) a rising detection of nonfunctional incidentalomas and (2) histological documentation of millimetric sources of clinically overt PA. Numerous limitations of AVS (an invasive, costly, and technically challenging procedure, with scarce availability) have driven efforts to develop alternative modalities to localize PA sources. In addition, growing understanding of PA pathophysiology has challenged the gold-standard status of AVS for PA subtyping. This perspective discusses the evolving role of AVS in contemporary PA management.<\/jats:p>","DOI":"10.1210\/clinem\/dgaf204","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T02:07:05Z","timestamp":1743386825000},"page":"e2800-e2803","source":"Crossref","is-referenced-by-count":7,"title":["Adrenal Vein Sampling in Primary Aldosteronism\u2014Is The Gold Standard Losing Its Luster?"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2465-1986","authenticated-orcid":false,"given":"Jaap","family":"Deinum","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Radboud University Medical Center , 6500 HB Nijmegen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9831-6190","authenticated-orcid":false,"given":"Adina F","family":"Turcu","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, University of Michigan , Ann Arbor, MI 48109 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"issue":"1","key":"2025071507120014100_dgaf204-B1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"7-08","key":"2025071507120014100_dgaf204-B2","first-page":"394","article-title":"Primary aldosteronism prevalence\u2014an unfolding story","volume":"131","author":"Charoensri","year":"2023","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"10304","key":"2025071507120014100_dgaf204-B3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"2025071507120014100_dgaf204-B4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"2025071507120014100_dgaf204-B5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneph.2013.110","article-title":"Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis","volume":"9","author":"Brown","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"2025071507120014100_dgaf204-B6","doi-asserted-by":"crossref","first-page":"e1280","DOI":"10.1210\/clinem\/dgad654","article-title":"Time to benefit of surgery vs targeted medical therapy for patients with primary aldosteronism: a meta-analysis","volume":"109","author":"Samnani","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025071507120014100_dgaf204-B7","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"20","key":"2025071507120014100_dgaf204-B8","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJM196711162772002","article-title":"Diagnosis and localization of aldosterone-producing adenomas by adrenal-vein catheterization","volume":"277","author":"Melby","year":"1967","journal-title":"N Engl J Med"},{"issue":"3","key":"2025071507120014100_dgaf204-B9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ecl.2017.04.009","article-title":"Adrenal imaging","volume":"46","author":"Mendiratta-Lala","year":"2017","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"11","key":"2025071507120014100_dgaf204-B10","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","article-title":"Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study","volume":"8","author":"Ebbehoj","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2025071507120014100_dgaf204-B11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/CIRCULATIONAHA.117.028201","article-title":"Age-related autonomous aldosteronism","volume":"136","author":"Nanba","year":"2017","journal-title":"Circulation"},{"issue":"5","key":"2025071507120014100_dgaf204-B12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med"},{"issue":"10","key":"2025071507120014100_dgaf204-B13","doi-asserted-by":"crossref","first-page":"e3628","DOI":"10.1210\/clinem\/dgaa482","article-title":"The concordance between imaging and adrenal vein sampling varies with aldosterone-driver somatic mutation","volume":"105","author":"Wannachalee","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025071507120014100_dgaf204-B14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/HYPERTENSIONAHA.118.11382","article-title":"Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism","volume":"72","author":"Williams","year":"2018","journal-title":"Hypertension"},{"issue":"3","key":"2025071507120014100_dgaf204-B15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/HYPERTENSIONAHA.123.21910","article-title":"Multifocal, asymmetric bilateral primary aldosteronism cannot be excluded by strong adrenal vein sampling lateralization: an international retrospective cohort study","volume":"81","author":"Turcu","year":"2024","journal-title":"Hypertension"},{"issue":"1-2","key":"2025071507120014100_dgaf204-B16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mce.2013.11.022","article-title":"Development of monoclonal antibodies against human CYP11B1 and CYP11B2","volume":"383","author":"Gomez-Sanchez","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"2025071507120014100_dgaf204-B17","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/HYPERTENSIONAHA.114.04812","article-title":"Influence of diagnostic criteria on the interpretation of adrenal vein sampling","volume":"65","author":"Lethielleux","year":"2015","journal-title":"Hypertension"},{"key":"2025071507120014100_dgaf204-B18","doi-asserted-by":"crossref","first-page":"644382","DOI":"10.3389\/fendo.2021.644382","article-title":"Aldosterone-regulating receptors and aldosterone-driver somatic mutations","volume":"12","author":"Lim","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"2025071507120014100_dgaf204-B19","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1210\/jc.2019-01182","article-title":"Three discrete patterns of primary aldosteronism lateralization in response to cosyntropin during adrenal vein sampling","volume":"104","author":"Wannachalee","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025071507120014100_dgaf204-B20","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2015-3915","article-title":"Basal and post-ACTH aldosterone and its ratios are useful during adrenal vein sampling in primary aldosteronism","volume":"101","author":"El Ghorayeb","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025071507120014100_dgaf204-B21","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/HYPERTENSIONAHA.110.168484","article-title":"Adrenal venous sampling: evaluation of the German Conn's registry","volume":"57","author":"Vonend","year":"2011","journal-title":"Hypertension"},{"issue":"1","key":"2025071507120014100_dgaf204-B22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41591-022-02114-5","article-title":"[(11)C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial","volume":"29","author":"Wu","year":"2023","journal-title":"Nat Med"},{"issue":"9","key":"2025071507120014100_dgaf204-B23","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2025071507120014100_dgaf204-B24","doi-asserted-by":"crossref","first-page":"e837","DOI":"10.1210\/clinem\/dgad451","article-title":"Predicting bilateral subtypes of primary aldosteronism without adrenal vein sampling: a systematic review and meta-analysis","volume":"109","author":"Ng","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025071507120014100_dgaf204-B25","doi-asserted-by":"crossref","first-page":"e210532","DOI":"10.1530\/EC-21-0532","article-title":"Validation of three novel clinical prediction tools for primary aldosteronism subtyping","volume":"11","author":"Kocjan","year":"2022","journal-title":"Endocr Connect"},{"issue":"4","key":"2025071507120014100_dgaf204-B26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/ajh\/hpab195","article-title":"External validation of clinical prediction models in unilateral primary aldosteronism","volume":"35","author":"Sam","year":"2022","journal-title":"Am J Hypertens"},{"issue":"6","key":"2025071507120014100_dgaf204-B27","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/HYPERTENSIONAHA.118.12064","article-title":"18-Oxocortisol synthesis in aldosterone-producing adrenocortical adenoma and significance of KCNJ5 mutation status","volume":"73","author":"Tezuka","year":"2019","journal-title":"Hypertension"},{"issue":"5","key":"2025071507120014100_dgaf204-B28","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.114.04453","article-title":"Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism","volume":"65","author":"Satoh","year":"2015","journal-title":"Hypertension"},{"issue":"1","key":"2025071507120014100_dgaf204-B29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/HYPERTENSIONAHA.119.13866","article-title":"Comprehensive analysis of steroid biomarkers for guiding primary aldosteronism subtyping","volume":"75","author":"Turcu","year":"2020","journal-title":"Hypertension"},{"issue":"9","key":"2025071507120014100_dgaf204-B30","doi-asserted-by":"crossref","first-page":"e2016209","DOI":"10.1001\/jamanetworkopen.2020.16209","article-title":"Use of steroid profiling combined with machine learning for identification and subtype classification in primary aldosteronism","volume":"3","author":"Eisenhofer","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2025071507120014100_dgaf204-B31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.7326\/ANNALS-24-00761","article-title":"Molecular imaging versus adrenal vein sampling for the detection of surgically curable primary aldosteronism : a prospective within-patient trial","volume":"178","author":"Goodchild","year":"2025","journal-title":"Ann Intern Med"},{"issue":"2","key":"2025071507120014100_dgaf204-B32","doi-asserted-by":"crossref","first-page":"e2255609","DOI":"10.1001\/jamanetworkopen.2022.55609","article-title":"Accuracy of gallium-68 pentixafor positron emission tomography-computed tomography for subtyping diagnosis of primary aldosteronism","volume":"6","author":"Hu","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"2025071507120014100_dgaf204-B33","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00259-022-05957-9","article-title":"First-in-human evaluation of [(18)F]CETO: a novel tracer for adrenocortical tumours","volume":"50","author":"Silins","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"2025071507120014100_dgaf204-B34","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2967\/jnumed.124.268425","article-title":"A phase I\/IIa clinical trial to evaluate safety and adrenal uptake of para-chloro-2-[(18)F]Fluoroethyletomidate in healthy volunteers and patients with primary aldosteronism","volume":"66","author":"Gillett","year":"2025","journal-title":"J Nucl Med"},{"issue":"13","key":"2025071507120014100_dgaf204-B35","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1021\/acs.jmedchem.1c00539","article-title":"Development of [(18)F]AldoView as the first highly selective aldosterone synthase PET tracer for imaging of primary hyperaldosteronism","volume":"64","author":"Sander","year":"2021","journal-title":"J Med Chem"},{"issue":"10479","key":"2025071507120014100_dgaf204-B36","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(24)02755-7","article-title":"Endoscopic, ultrasound-guided, radiofrequency ablation of aldosterone-producing adenomas (FABULAS): a UK, multicentre, prospective, proof-of-concept trial","volume":"405","author":"Argentesi","year":"2025","journal-title":"Lancet"},{"issue":"11","key":"2025071507120014100_dgaf204-B37","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","article-title":"Primary aldosteronism\u2014a multidimensional syndrome","volume":"18","author":"Turcu","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"7653","key":"2025071507120014100_dgaf204-B38","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","article-title":"Grading quality of evidence and strength of recommendations for diagnostic tests and strategies","volume":"336","author":"Sch\u00fcnemann","year":"2008","journal-title":"BMJ"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf204\/62837004\/dgaf204.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/8\/e2800\/62837004\/dgaf204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/8\/e2800\/62837004\/dgaf204.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:12:15Z","timestamp":1752577935000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/8\/e2800\/8103434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,4,2]]},"published-print":{"date-parts":[[2025,7,15]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf204","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,4,2]]}}}